Silence Therapeutics PLC (SLN NASDAQ) stock market data APIs
$14.2338
0.07(0.5%)
as of August 18, 2026
Try our APIs with
free plan!
Silence Therapeutics PLC Financial Data Overview
Price chart is built with
Anychart
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Prev. Close
14.2338
Open
14.3038
High
14.3238
Low
13.6124
52 wk Range
4.19-17.576
Market Cap
678 M
Shares Outstanding
47 247 K
Revenue
615 K
EPS
-0.26
Beta
1.411
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Silence Therapeutics PLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Silence Therapeutics PLC data using free add-ons & libraries
Get Silence Therapeutics PLC Fundamental Data
Silence Therapeutics PLC Fundamental data includes:
- Net Revenue: 615 K
- EBITDA: -63 942 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Silence Therapeutics PLC Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-10
- EPS/Forecast: -0.32
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Silence Therapeutics PLC News
New
Silence Therapeutics prices upsized $175M ADS offering at $13.50 each
* Silence Therapeutics (SLN [https://seekingalpha.com/symbol/SLN]) priced an upsized underwritten public offering of 12.96M ADSs at $13.50 each, raising ~$175M in gross proceeds. * The underwriter...
Silence Therapeutics Announces Public Offering Worth $150 Mln In American Depositary Shares
(RTTNews) - Silence Therapeutics plc (SLN), a biotechnology company, announced a proposed public offering for $150 million worth of American Depositary Shares (ADSs). Each ADS represents £0.05 in c...
Biotech Stocks At 52-Week Highs - SLN +29% & ABCL +34% On Positive Trial Data, CPIX, CLDX, BDSX
(RTTNews) - The following biotech stocks reached a 52-week high on August 10, 2026, driven by key catalysts such as positive quarterly reports or the release of promising results from clinical trials....
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inf...
Get Silence Therapeutics PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
